Tulane University researchers and collaborators have discovered a new biological activity in a small protein from the deadly Ebola virus. A compound known as the “delta peptide” is produced in large amounts [Read more]
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye. Using an ultra widefield [Read more]
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Virology Division, Pathogenesis and Immunology Branch has been tasked by the Defense Threat Reduction Agency to investigate a potential for enhanced efficacy [Read more]
Pacific Northwest National Laboratory scientists were recently recognized by the Secretary of the Department of Energy (DOE) for their role helping to stem the Ebola epidemic in West Africa two years ago. [Read more]
John Kash, researcher from the National Institute of Allergy and Infectious Disease (NIAID) Viral Pathogenesis and Evolution Section, with his colleagues, carefully tracked changes in gene expression that occurred in a 34-year-old [Read more]
The Biomedical Advanced Research and Development Authority (BARDA) has issued two pre-solicitation notices supporting mid- and late-phase development of medical countermeasures for Ebola Virus Disease (EVD). There are currently no vaccines or therapeutics [Read more]
A study led by scientists at the University of Texas Medical Branch Galveston National Laboratory and Mapp Biopharmaceutical has found that an experimental treatment cured 100 percent of guinea pigs and rhesus [Read more]
UNSEEN ENEMY, about the potential looming crisis of disease pandemics, will debut as a CNN Films broadcast for a World Health Day presentation Friday, April 7 at 9:00pm Eastern on CNN/U.S. UNSEEN [Read more]
A class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival. [Read more]
By Rebecca Fish The United States continues to face national security risks from natural, accidental , and intentional health threats. Efforts to improve chemical, biological, radiological and nuclear threats (CBRN) and emerging [Read more]
© 2017 Global Biodefense